Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Lupin Ltd.
NSE: LUPIN
|
BSE: 500257
|
ISIN: INE326A01037
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
2496.3000
-7.00
(
-0.28
%)
NSE
Jul 10, 2026
15:31 PM
New 52W High in past week
Volume:
568.4K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Lupin Ltd.
16 Feb 2026
2496.30
-0.28%
Result Update:Lupin
Buy:
Lupin Ltd.
by
Axis Direct
Target: 2460 | Target met
Target
Axis Direct
We recommend a BUY rating with a target price of Rs 2,460/share.
Number of FII/FPI investors increased from 966 to 979 in Mar 2026 qtr.
More from Lupin Ltd.
Recommended
Five Interesting Stocks Today - July 10, 2026
The Baseline |
10 Jul 2026
Market closes higher, driven by easing oil prices and gains in realty and IT stocks
Trendlyne Marketwatch |
10 Jul 2026
Lupin expects normalization by September quarter
|
17 Apr 2020